Upon completion of this activity, participants should be able to assess the current use of FDA-approved biologic agents for the treatment of psoriatic arthritis in your practice and identify opportunities to better educate patients about drug efficacy and safety to improve overall adherence.

Upon completion of this activity, participants should be able to assess the most common clinical examination and laboratory findings in patients presenting with possible psoriatic arthritis (PsA) and identify the specific characteristics of PsA that differentiate the condition from other common rheumatic diseases.

What does a national survey of rheumatologists and dermatologists tell us about psoriatic arthritis (PsA) care, and how can we improve? In 2018, a steering […]

In this issue of Rheumatology Nurse Practice, we explore the options available to measure and track disease activity levels in patients with psoriatic arthritis and offer guidance on how these can be smoothly incorporated into routine clinical practice.

Upon completion of this activity, participants should be able to: (1) Apply lessons from case studies of patients with psoriatic arthritis (PsA) into the clinical setting, and (2) Discuss the importance of managing issues such as comorbidities, side effects, and drug adherence in patients with PsA...

Upon completion of this activity, participants should be able to: (1) Discuss the importance of managing issues such as comorbidities, side effects, and drug adherence in patients with psoriatic arthritis (PsA), and (2) Apply lessons from case studies of patients with PsA into the clinical setting...

Upon completion of this activity, participants should be able to: (1) Apply lessons from case studies of patients with psoriatic arthritis (PsA) into the clinical setting, and (2) Discuss the importance of managing issues such as comorbidities, side effects, and drug adherence in patients with PsA...

The goal of this activity is to increase awareness in targeted treatments for rheumatoid arthritis (RA) and psoriatic arthritis (PsA), as well as the potential impact of biosimilar medicines in rheumatology clinical practice.

In this issue we will explore the pathways that new agents under investigation for the treatment of psoriatic arthritis (PsA) are targeting. We will also examine the potential role of biosimilars for patients with PsA as they are introduced more commonly into clinical care.

We will take a look at current and anticipated guideline recommendations for treatment of PsA, the efficacy and safety of biologic and other agents, considerations in the selection and switching of therapy, and real-life practice trends.

A chapter from HANDLING THE HARD QUESTIONS: What Our Patients Are Asking Us About Rheumatic Disease Read and download this booklet on our Workforce Resource […]

A chapter from HANDLING THE HARD QUESTIONS: What Our Patients Are Asking Us About Rheumatic Disease Read and download this booklet on our Workforce Resource […]

A chapter from HANDLING THE HARD QUESTIONS: What Our Patients Are Asking Us About Rheumatic Disease Read and download this booklet on our Workforce Resource […]

I first met AP, a 48-year-old woman, about 8 years ago when I was new at my current rheumatology practice. From the very start of […]

A few months ago, a new patient, SR, came into our office with a long and varied history of rheumatic disease. A 34-year-old Caucasian male […]

The treat-to-target approach to care is a hot topic in medicine and is now widely accepted as a best practice in our patients diagnosed with […]

A very long time ago in my nursing school days, I learned that each kidney has approximately 1 million nephrons comprised of convoluted tubules. Their […]

I have been caring for KN, a 57-year-old woman with psoriatic arthritis (PsA) for approximately 9 months. When she initially presented to our office, she […]

When I started in rheumatology practice 11 years ago, we had few options at our disposal to treat patients with psoriatic arthritis (PsA). The initial […]

There are a number of treatment guidelines/recommendations available in nearly every disease state that are based on high-quality clinical evidence. These guidelines typically take many […]

Treating patients with psoriatic arthritis (PsA) can be challenging when they fail to respond or lose their response to a specific therapy. Although we are […]

Two years ago, a 30-year-old woman (RB) came to our office for an initial consult. She was in a wheelchair, covered from head to toe […]